Skip to main content
Log in

Evaluation of cathepsin D as a prognostic factor in breast cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The biologic rationale for the importance of cathepsin D in breast cancer is a provocative one. Cathepsin D is both an estrogen inducible and a constitutively produced protease, which may also act directly as a peptide growth factor. Thus it may play a role in tumor invasiveness, and also in driving cell proliferation. Reported clinical studies are conflicting, with some studies showing cathepsin D levels to correlate with clinical outcome, and other studies finding prognostic significance only in selected subsets of patients, if any. Thus cathepsin D is a potentially important prognostic marker whose clinical application awaits further definition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Westley B, Rochefort H: A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20:352–362, 1980.

    Google Scholar 

  2. Morisset M, Capony F, Rochefort H: The 52 kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun 138:102–109, 1986.

    PubMed  Google Scholar 

  3. Augereau P, Garcia M, Mattei MG, Cavailles V, Depadova F, Derocq D, Capony F, Ferrara P, Rochefort H: Cloning sequencing of the 52K cathepsin D complementary DNA of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol 2:186–192, 1988.

    PubMed  Google Scholar 

  4. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H: Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cells. Cancer Res 49: 3904–3909, 1989.

    PubMed  Google Scholar 

  5. Capony F, Morisset M, Barrett AJ, Capony JP, Briozzo P, Vignon F, Chambon M, Louisot P, Rochefort H: Phosphorylation, glycosylation, and proteolytic activity of the 52K estrogen induced protein of MCF-7 cells. J Cell Biol 104:253–262, 1987.

    PubMed  Google Scholar 

  6. Rochefort H, Cavailles V, Augereau P, Capony F, Maudelonde T, Touitou I, Garcia M: Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem 34:177–182, 1989.

    PubMed  Google Scholar 

  7. Touitou I, Cavailles V, Garcia M, Defrenne A, Rochefort H: Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells. Mol Cell Endocrinol 66:231–238, 1989.

    PubMed  Google Scholar 

  8. Cavailles V, Augereau P, Garcia M, Rochefort H: Estrogens and growth factors induce mRNA of the procathepsin D secreted by breast cancer cells. Nucl Acid Res 16:1903–1919, 1988.

    Google Scholar 

  9. Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H: Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 118:1537–1545, 1986.

    PubMed  Google Scholar 

  10. Mathieu M, Rochefort H, Brenton B, Prebois C, Vignon F: Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4:1327–1335, 1990.

    PubMed  Google Scholar 

  11. Rochefort H, Capony F, Garcia M: Cathepsin D: A protease involved in breast cancer metastasis. Cancer and Metastasis Reviews 9:321–331, 1990.

    PubMed  Google Scholar 

  12. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, Rochefort H: MCF-7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 194:252–259, 1991.

    PubMed  Google Scholar 

  13. Garcia M, Derocq D, Pujol P, Rochefort H: Over-expression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5:1809–1814, 1990.

    PubMed  Google Scholar 

  14. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48:3688–3892, 1988.

    PubMed  Google Scholar 

  15. Rogler H, Freiss G, Besse M-G, Cavalle-Barthez G, Garcia M, Pau B, Rochefort H, Paolucci F: Two-site immunoenzymatic assay for the 52 kDa cathepsin D in cytosols of breast cancer tissues. Clin Chem 35:81–85, 1989.

    PubMed  Google Scholar 

  16. Hilsenbeck SG, Clark GM, McGuire WL: Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat 22:197–206, 1992.

    PubMed  Google Scholar 

  17. Thorpe SM, Rochefort H, Garcia M, Freiss G, Christensen JJ, Khalaf S, Paolucci F, Pau B, Rasmussen BB, Rose C: Association between high concentration of Mw 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res 49:6008–6014, 1989.

    PubMed  Google Scholar 

  18. Spyratos F, Brouillet JP, Defrenne A, Hacene K, Rouesse J, Maudelonde T, Brunet M, Andrieu C, Desplaces A, Rochefort H: Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet ii:1115–1118, 1989.

    Google Scholar 

  19. Romain S, Muracciole X, Varette I, Bressac C, Brandone H, Martin PM: La cathepsin D: un facteur pronostique independant dans le cancer du sein. Bull Cancer (Paris) 77:439–447, 1990.

    PubMed  Google Scholar 

  20. Duffy MJ, Brouillet JP, Reilly D, McDermott E, O'Higgins N, Fennelly JJ, Maudelonde T, Rochefort H: Cathepsin-D concentration in breast cancer cytosols: correlation with biochemical, histological and clinical findings. Clin Chem 37:101–104, 1991.

    PubMed  Google Scholar 

  21. Namer M, Ramaioli A, Fontana X, Etienne MC, Héry M, Jourlait A, Milano G, Frenay M, Franćçois E, Lapalus F: Prognostic value of total cathepsin D in breast cancer. Breast Cancer Res Treat 19:85–93, 1991.

    PubMed  Google Scholar 

  22. Granata G, Coradini D, Cappelletti V, Di Fronzo G: Prognostic relevance of cathepsin-D versus oestrogen receptors in node-negative breast cancers. Eur J Cancer 27:970–972, 1991.

    PubMed  Google Scholar 

  23. Kute TE, Shao L-M, Sugg K, Long RT, Russell GB, Case LD: Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res 52:1–6, 1992.

    PubMed  Google Scholar 

  24. Pujol P, Maudelonde T, Daures JP, Rouanet JP, Brouillet JP, Pujol H, Rochefort H: Prospective study on the prognostic values of cathepsin D levels in breast cancer. Cancer, in press, 1992.

  25. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL: Cathepsin-D and prognosis in breast cancer. N Engl J Med 322:297–302, 1990.

    PubMed  Google Scholar 

  26. Henry JA, McCarthy AL, Angus B, Westley BR, May FE, Nicholson S, Cairos J, Harris AL, Horne CH: Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: an immunohistochemical study. Cancer 65:265–271, 1990.

    PubMed  Google Scholar 

  27. Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H, Graeff H: Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat (this issue).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ravdin, P.M. Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res Tr 24, 219–226 (1993). https://doi.org/10.1007/BF01833262

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01833262

Key words

Navigation